Identification and validation of new therapeutic targets in pediatric leukemia through an aneuploidy-based synthetic lethality screen |
Dana-Farber Cancer Institute / David Pellman, MD |
Innovation Grants |
2012 |
Massachusetts |
Casein Kinase 1 alpha Agonists as Novel Medulloblastoma Inhibitors |
University of Miami Miller School of Medicine / David Robbins, PhD |
Innovation Grants |
2012 |
Florida |
Cooperating Genes for inv16 Acute Myeloid Leukemia |
University of Massachusetts Medical School / Lucio Castilla |
Bridge Grants |
2012 |
Massachusetts |
A Combinatorial Approach to Target the Tumor-Initiating and Transit Amplifying Cellular Subpopulations in Diffuse Intrinsic Pontine Glioma (DIPG) |
Stanford University / Michelle Monje, MD, PhD |
'A' Award Grants |
2011 |
California |
The role of primary cilia in rhabdomyosarcoma |
New York University School of Medicine / Brian Dynlacht, PhD |
Innovation Grants |
2011 |
New York |
Preliminary Content Validation Steps for the Pediatric Oncology Patient Self-Report CTCAE |
Children’s National Medical Center / Pamela Hinds |
Nurse Researcher Grants |
2011 |
District of Columbia |
Investigating the Role of Lin-28 in Germ Cell Tumorigenesis |
Boston Children’s Hospital / George Daley, MD/PhD |
Innovation Grants |
2011 |
Massachusetts |
Using zebrafish to model the molecular origins of pediatric myeloid malignancies and acute myeloid leukemia |
Dana-Farber Cancer Institute / Evisa Gjini |
Young Investigator Grants |
2011 |
Massachusetts |
BH3 Profiling to define therapy resistance classes in neuroblastoma |
Children’s Hospital of Philadelphia / Michael Hogarty, MD |
Innovation Grants |
2011 |
Pennsylvania |
Altering master genetic regulators SNF5/INI1 and LIN28A to model and treat atypical teratoid/rhabdoid tumors |
The Johns Hopkins University School of Medicine / Eric Raabe |
Young Investigator Grants |
2011 |
Maryland |